Where the Comment is King

THE NEWS COMMENTER

VOTE  (0)  (0)

Merck Seeks Emergency Approval for COVID-19 Oral COVID Treatment

Added 10-03-21 12:38:01pm EST - “Merck's new medication, molnupiravir, works by inhibiting the mechanisms by which the virus replicates.” - Legalinsurrection.com

CLICK TO SHARE

Posted By TheNewsCommenter: From Legalinsurrection.com: “Merck Seeks Emergency Approval for COVID-19 Oral COVID Treatment”. Below is an excerpt from the article.

Merck’s new medication, molnupiravir, works by inhibiting the mechanisms by which the virus replicates.

As I have noted many times before, an effective COVID-19 response plans will include focus in effective and inexpensive treatments.

Merck plans to request emergency approval for an experimental oral COVID-19 antiviral drug, molnupiravir, after a late-stage trial indicated an approximate 50% risk reduction for hospitalization or death among patients with mild to moderate COVID-19.

An interim analysis, stemming from the Phase 3 MOVe-OUT trial, indicated 7.3% of patients who received molnupiravir were hospitalized or had died about a month later, compared with 14.1% of patients receiving a placebo. The company also reported no deaths in the treatment group, versus eight deaths in the placebo group.

“Merck plans to submit an application for Emergency Use Authorization (EUA) to the U.S. FDA as soon as possible based on these findings and plans to submit marketing applications to other regulatory bodies worldwide,” the company said Friday.

Read more...

Watch the video:



If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.

Comment Box is loading comments...

CLICK TO SHARE

BACK TO THE HOME-PAGE